Why the study?
Does ISO1 improve axonal regeneration and behavioral recovery in lampreys after spinal cord transection?
Does ISO1 improve axonal regeneration and behavioral recovery in lampreys after spinal cord transection?
MIF inhibition with ISO1 enhances axon regeneration and behavioral recovery following spinal cord injury in a lamprey model.
MIF inhibition may aid lamprey SCI recovery; leaves open translation to mammalian models or clinical use.
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that regulates a portion of the immune response and that has been implicated in the inhibition of neuronal recovery following spinal cord injury. My hypothesis is that MIF inhibits neuronal recovery by increasing the inflammatory response as well as the buildup of scar tissue.To test this hypothesis, MIF was inhibited in the lamprey after spinal cord transection via administration of the drug ISO1, a small protein that inhibits the enzymatic activity of MIF. The behavioral recovery was then measured over thirteen week period by scoring swimming patterns. Axonal regeneration was measured through retrograde labeling of the somata of giant reticulospinal axons. Results indicate that MIF inhibition led to a 60.6% increase in axon regeneration, as well as more complete behavioral recovery. These results suggest the possibility of the MIF inhibition being a viable treatment for neural recovery following spinal cord injury.
No takes yet. Share an insight, caveat, or question.
Akila Amsavelu (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: